XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) Fundamental Analysis & Valuation

NASDAQ:XOMAO • US98419J4040

Current stock price

26.0432 USD
+0.03 (+0.13%)
Last:

This XOMAO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. XOMAO Profitability Analysis

1.1 Basic Checks

  • XOMAO had positive earnings in the past year.
  • XOMAO had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: XOMAO reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: XOMAO reported negative operating cash flow in multiple years.
XOMAO Yearly Net Income VS EBIT VS OCF VS FCFXOMAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

  • The Return On Assets of XOMAO (6.80%) is better than 92.26% of its industry peers.
  • The Return On Equity of XOMAO (17.83%) is better than 94.78% of its industry peers.
  • XOMAO's Return On Invested Capital of 3.78% is amongst the best of the industry. XOMAO outperforms 89.56% of its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 17.83%
ROIC 3.78%
ROA(3y)-7.23%
ROA(5y)-6.6%
ROE(3y)-19.31%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A
XOMAO Yearly ROA, ROE, ROICXOMAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800 1K

1.3 Margins

  • With an excellent Profit Margin value of 35.54%, XOMAO belongs to the best of the industry, outperforming 96.13% of the companies in the same industry.
  • In the last couple of years the Profit Margin of XOMAO has grown nicely.
  • The Operating Margin of XOMAO (21.83%) is better than 94.00% of its industry peers.
  • In the last couple of years the Operating Margin of XOMAO has declined.
Industry RankSector Rank
OM 21.83%
PM (TTM) 35.54%
GM N/A
OM growth 3YN/A
OM growth 5Y-12.38%
PM growth 3YN/A
PM growth 5Y2.98%
GM growth 3YN/A
GM growth 5YN/A
XOMAO Yearly Profit, Operating, Gross MarginsXOMAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XOMAO Health Analysis

2.1 Basic Checks

  • XOMAO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • XOMAO has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for XOMAO has been increased compared to 5 years ago.
  • The debt/assets ratio for XOMAO has been reduced compared to a year ago.
XOMAO Yearly Shares OutstandingXOMAO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
XOMAO Yearly Total Debt VS Total AssetsXOMAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -4.43, we must say that XOMAO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -4.43, XOMAO is not doing good in the industry: 60.73% of the companies in the same industry are doing better.
  • XOMAO has a debt to FCF ratio of 37.96. This is a negative value and a sign of low solvency as XOMAO would need 37.96 years to pay back of all of its debts.
  • The Debt to FCF ratio of XOMAO (37.96) is better than 89.36% of its industry peers.
  • A Debt/Equity ratio of 0.93 indicates that XOMAO is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.93, XOMAO is doing worse than 74.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 37.96
Altman-Z -4.43
ROIC/WACC0.38
WACC9.94%
XOMAO Yearly LT Debt VS Equity VS FCFXOMAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that XOMAO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.37, XOMAO is in line with its industry, outperforming 41.20% of the companies in the same industry.
  • A Quick Ratio of 3.37 indicates that XOMAO has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.37, XOMAO is in line with its industry, outperforming 43.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
XOMAO Yearly Current Assets VS Current LiabilitesXOMAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. XOMAO Growth Analysis

3.1 Past

  • XOMAO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 170.87%, which is quite impressive.
  • The Earnings Per Share has been growing by 29.56% on average over the past years. This is a very strong growth
  • Looking at the last year, XOMAO shows a very strong growth in Revenue. The Revenue has grown by 73.96%.
  • XOMAO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.15% yearly.
EPS 1Y (TTM)170.87%
EPS 3YN/A
EPS 5Y29.56%
EPS Q2Q%157.78%
Revenue 1Y (TTM)73.96%
Revenue growth 3Y105.26%
Revenue growth 5Y12.15%
Sales Q2Q%57.87%

3.2 Future

  • Based on estimates for the next years, XOMAO will show a decrease in Earnings Per Share. The EPS will decrease by -8.80% on average per year.
  • XOMAO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.50% yearly.
EPS Next Y-78.46%
EPS Next 2Y-8.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.91%
Revenue Next 2Y11.05%
Revenue Next 3Y18.11%
Revenue Next 5Y32.5%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XOMAO Yearly Revenue VS EstimatesXOMAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
XOMAO Yearly EPS VS EstimatesXOMAO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

5

4. XOMAO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.84, XOMAO is valued on the expensive side.
  • XOMAO's Price/Earnings ratio is rather cheap when compared to the industry. XOMAO is cheaper than 94.00% of the companies in the same industry.
  • XOMAO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.91.
  • The Price/Forward Earnings ratio is 82.83, which means the current valuation is very expensive for XOMAO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of XOMAO indicates a rather cheap valuation: XOMAO is cheaper than 88.59% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, XOMAO is valued quite expensively.
Industry RankSector Rank
PE 17.84
Fwd PE 82.83
XOMAO Price Earnings VS Forward Price EarningsXOMAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • XOMAO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XOMAO is cheaper than 92.26% of the companies in the same industry.
  • XOMAO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. XOMAO is cheaper than 90.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 112.3
EV/EBITDA 24.19
XOMAO Per share dataXOMAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • XOMAO has a very decent profitability rating, which may justify a higher PE ratio.
  • XOMAO's earnings are expected to decrease with -8.80% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.6
EPS Next 2Y-8.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. XOMAO Dividend Analysis

5.1 Amount

  • XOMAO has a Yearly Dividend Yield of 8.17%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.11, XOMAO pays a better dividend. On top of this XOMAO pays more dividend than 99.81% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, XOMAO pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.17%

5.2 History

  • XOMAO has been paying a dividend for over 5 years, so it has already some track record.
  • XOMAO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
XOMAO Yearly Dividends per shareXOMAO Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • XOMAO pays out 29.53% of its income as dividend. This is a sustainable payout ratio.
DP29.53%
EPS Next 2Y-8.8%
EPS Next 3YN/A
XOMAO Yearly Income VS Free CF VS DividendXOMAO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M
XOMAO Dividend Payout.XOMAO Dividend Payout, showing the Payout Ratio.XOMAO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

XOMAO Fundamentals: All Metrics, Ratios and Statistics

XOMA ROYALTY CORP - XOMA 8 3/8 PERP

NASDAQ:XOMAO (4/9/2026, 4:30:03 PM)

26.0432

+0.03 (+0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)04-30
Inst Owners70.51%
Inst Owner ChangeN/A
Ins Owners1.79%
Ins Owner ChangeN/A
Market Cap322.41M
Revenue(TTM)52.15M
Net Income(TTM)18.53M
Analysts81.82
Price Target66 (153.43%)
Short Float %0.03%
Short Ratio1.47
Dividend
Industry RankSector Rank
Dividend Yield 8.17%
Yearly Dividend0.46
Dividend Growth(5Y)N/A
DP29.53%
Div Incr Years0
Div Non Decr Years4
Ex-Date04-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1040.07%
Min EPS beat(2)264.45%
Max EPS beat(2)1815.69%
EPS beat(4)4
Avg EPS beat(4)623.83%
Min EPS beat(4)119.7%
Max EPS beat(4)1815.69%
EPS beat(8)5
Avg EPS beat(8)324.56%
EPS beat(12)6
Avg EPS beat(12)211.09%
EPS beat(16)7
Avg EPS beat(16)137.03%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-20.06%
Max Revenue beat(2)22.07%
Revenue beat(4)3
Avg Revenue beat(4)38.88%
Min Revenue beat(4)-20.06%
Max Revenue beat(4)120.82%
Revenue beat(8)6
Avg Revenue beat(8)25.22%
Revenue beat(12)7
Avg Revenue beat(12)14.07%
Revenue beat(16)8
Avg Revenue beat(16)2.21%
PT rev (1m)0%
PT rev (3m)-0.47%
EPS NQ rev (1m)126.32%
EPS NQ rev (3m)126.32%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.32%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-4.64%
Valuation
Industry RankSector Rank
PE 17.84
Fwd PE 82.83
P/S 6.18
P/FCF 112.3
P/OCF 112.3
P/B 3.1
P/tB 5.45
EV/EBITDA 24.19
EPS(TTM)1.46
EY5.61%
EPS(NY)0.31
Fwd EY1.21%
FCF(TTM)0.23
FCFY0.89%
OCF(TTM)0.23
OCFY0.89%
SpS4.21
BVpS8.4
TBVpS4.78
PEG (NY)N/A
PEG (5Y)0.6
Graham Number16.61
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 17.83%
ROCE 4.79%
ROIC 3.78%
ROICexc 5.82%
ROICexgc 8.19%
OM 21.83%
PM (TTM) 35.54%
GM N/A
FCFM 5.51%
ROA(3y)-7.23%
ROA(5y)-6.6%
ROE(3y)-19.31%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-24.81%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.78%
OM growth 3YN/A
OM growth 5Y-12.38%
PM growth 3YN/A
PM growth 5Y2.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 37.96
Debt/EBITDA 6.72
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 0.96
Cash Conversion 20%
Profit Quality 15.49%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z -4.43
F-Score7
WACC9.94%
ROIC/WACC0.38
Cap/Depr(3y)3117.3%
Cap/Depr(5y)4643.1%
Cap/Sales(3y)23.75%
Cap/Sales(5y)64.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.87%
EPS 3YN/A
EPS 5Y29.56%
EPS Q2Q%157.78%
EPS Next Y-78.46%
EPS Next 2Y-8.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)73.96%
Revenue growth 3Y105.26%
Revenue growth 5Y12.15%
Sales Q2Q%57.87%
Revenue Next Year28.91%
Revenue Next 2Y11.05%
Revenue Next 3Y18.11%
Revenue Next 5Y32.5%
EBIT growth 1Y191.25%
EBIT growth 3YN/A
EBIT growth 5Y-1.73%
EBIT Next Year117.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.46%
FCF growth 3YN/A
FCF growth 5Y-22.21%
OCF growth 1Y120.88%
OCF growth 3YN/A
OCF growth 5Y-22.23%

XOMA ROYALTY CORP - XOMA 8 3/8 PERP / XOMAO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

ChartMill assigns a fundamental rating of 6 / 10 to XOMAO.


What is the valuation status for XOMAO stock?

ChartMill assigns a valuation rating of 5 / 10 to XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO). This can be considered as Fairly Valued.


What is the profitability of XOMAO stock?

XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) has a profitability rating of 6 / 10.


Can you provide the financial health for XOMAO stock?

The financial health rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) is 5 / 10.


How sustainable is the dividend of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

The dividend rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) is 6 / 10 and the dividend payout ratio is 29.53%.